Reactive Arthritis News

Johns Hopkins Hospital has been recognized by U.S. News & World Report’s Best Hospitals Survey as the top-ranked hospital in the country for rheumatology for the 2018 to 2019 year.

Healio Rheumatology is proud to announce the launch of Rheuminations, a podcast series hosted by Adam Brown, MD, focusing on medical mysteries and other ripping yarns of the immune system gone awry.

BOSTON — The potential rheumatic side effects of checkpoint inhibitor therapy in patients with cancer can include arthralgia, arthritis, polymyalgia rheumatica, giant cell arteritis, myositis, sicca syndrome and systemic lupus erythematosus, and can be chronic in approximately 50% of patients, according to findings presented here.

Two FDA advisory committees will have a joint meeting on April 24-25, 2018 to discuss a supplemental new drug application submitted by Pfizer requesting an update of CV safety information on the labeling of celecoxib.

In a new post hoc analysis from the PRECISION trial, celecoxib had a better CV safety profile vs. ibuprofen and naproxen among patients not taking aspirin, but significant differences in CV events were not seen in patients taking aspirin.

Patients with arthritis who are younger, have rheumatoid factor positivity and demonstrate higher disease activity at baseline are at an increased risk for experiencing methotrexate failure due to inefficacy, according to findings published in Arthritis Care & Research.

The use of biologic medications for autoimmune diseases prior to or during pregnancy is not associated with an increased risk for preterm delivery or infants that are small for gestational age, according to findings published in the Annals of the Rheumatic Diseases.

Patients with early inflammatory polyarthritis diagnosed within the new millennium experienced improved disease activity, compared with those diagnosed during the early 1990s, according to findings published in the Annals of the Rheumatic Diseases.

Few patients with inflammatory arthritis reported participating in a structured self-management care program, although many physicians reported providing self-management support within routine care, according to findings published in Arthritis Care and Research.

One-quarter of Latin American patients with the mosquito-borne chikungunya virus continued to have joint pain 20 months following the initial infection, according to findings published in Arthritis and Rheumatology.